Study is first to find clear signs of enterovirus in the nervous system of AFM patients, providing the strongest evidence to date that the disease is viral.

Women with triple-negative breast cancer could be differentiated from a more common form of the disease by a panel of 17 small RNA molecules.

"Is it a boy or girl?". It's presumed that there's a 50-50 chance you'd have one or the other. However, a new study of the sex chromosomes suggest they genes which, at least in mice, skew that assumed ratio to favor one sex, could have major implications for male infertility.

In the second feature of "Technology Networks Explores the CRISPR Revolution", we speak with the world-renowned scientist, Professor Jennifer Doudna, the co-developer of CRISPR genome editing technology.

A pair of recent studies looked at the reliability of clinical observations and bacterial culture versus quantitative PCR (qPCR) in detecting clinically healthy carriers of the bacterium that causes strangles, who pose an infection risk to naïve individuals.

Kicking off Technology Networks Explores the CRISPR Revolution, Professor Mojica, or "Francis", takes us on a journey back to the original research that, despite being deemed "crazy" by members of the scientific community at the time, led to the CRISPR revolution that is anticipated to edit evolution forever.

Reproducibility is now recognized as a core feature of good scientific practice but too many papers fail to meet the grade. We talked to Leslie D McIntosh, CEO of Ripeta, on the topic of reproducibility. In this interview, we ask Leslie about the concepts within Ripeta’s recent report on the state of reproducible science in 2019.

Impostor syndrome is experienced by millions of people around the world cross culturally, and describes difficulty internalizing one's accomplishments or abilities, and instead attributing their success to other factors. In this article, we explore the prevalence of impostor syndrome in STEM and the impact it has on the scientific community.

Thus far, the feasibility to edit stem cells using CRISPR technology has been demonstrated in two key areas: modeling and investigating human cell states and human diseases, and regenerative medicine. In this article, we explore some of the latest research in these spaces and the approaches that scientists are adopting to overcome challenges in the field.